Business Description
Salarius Pharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : US33938A1051
Description
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 27.97 | |||||
| Equity-to-Asset | 0.67 | |||||
| Debt-to-Equity | 0.05 | |||||
| Debt-to-EBITDA | -0.02 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 31.3 | |||||
| 3-Year EPS without NRI Growth Rate | 33.3 | |||||
| 3-Year FCF Growth Rate | 38 | |||||
| 3-Year Book Growth Rate | -61.4 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 37.75 | |||||
| 9-Day RSI | 46.28 | |||||
| 14-Day RSI | 48.29 | |||||
| 6-1 Month Momentum % | -63.93 | |||||
| 12-1 Month Momentum % | -76.62 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.98 | |||||
| Quick Ratio | 2.98 | |||||
| Cash Ratio | 2.78 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -60.5 | |||||
| Shareholder Yield % | 0.45 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -125.22 | |||||
| ROA % | -91.08 | |||||
| ROIC % | -2795.61 | |||||
| 3-Year ROIIC % | 47.09 | |||||
| ROCE % | -130.62 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.44 | |||||
| Price-to-Tangible-Book | 0.44 | |||||
| EV-to-EBIT | 0.27 | |||||
| EV-to-EBITDA | 0.27 | |||||
| EV-to-FCF | 0.24 | |||||
| Price-to-Net-Current-Asset-Value | 0.45 | |||||
| Price-to-Net-Cash | 0.5 | |||||
| Earnings Yield (Greenblatt) % | 370.37 | |||||
| FCF Yield % | -329.02 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:SLRX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Salarius Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -10.85 | ||
| Beta | 0.09 | ||
| Volatility % | 67.75 | ||
| 14-Day RSI | 48.29 | ||
| 14-Day ATR ($) | 0.239799 | ||
| 20-Day SMA ($) | 1.6225 | ||
| 12-1 Month Momentum % | -76.62 | ||
| 52-Week Range ($) | 1.26 - 7.44 | ||
| Shares Outstanding (Mil) | 1.44 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Salarius Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Salarius Pharmaceuticals Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Salarius Pharmaceuticals Inc Frequently Asked Questions
What is Salarius Pharmaceuticals Inc(SLRX)'s stock price today?
The current price of SLRX is $1.62. The 52 week high of SLRX is $7.44 and 52 week low is $1.26.
When is next earnings date of Salarius Pharmaceuticals Inc(SLRX)?
The next earnings date of Salarius Pharmaceuticals Inc(SLRX) is .
Does Salarius Pharmaceuticals Inc(SLRX) pay dividends? If so, how much?
Salarius Pharmaceuticals Inc(SLRX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers